DETAILED ACTION
Applicant’s response, filed 09 July 2026 has been fully considered. The following rejections and/or objections are either reiterated or newly applied. They constitute the complete set presently being applied to the instant application.
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Continued Examination Under 37 CFR 1.114
A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 09 July 2026 has been entered.
Election/Restrictions
The restriction requirement in the Office action mailed 03 June 2025 has been withdrawn for the reasons discussed in the Office action mailed 05 Nov. 2025.
Status of Claims
Claims 4-5, 10, 12-15, and 17-18 are cancelled.
Claims 1-3, 6-9, 11, and 16 are pending.
Claims 1-3, 6-9, 11, and 16 are rejected.
Claims 1 and 16 are objected to.
Priority
Applicant’s claim for the benefit of a prior-filed application, PCT/IN2020/050346 filed 11 April 2020, under 35 U.S.C. 119(e) or under 35 U.S.C. 120, 121, 365(c), or 386(c) is acknowledged.
Acknowledgment is made of applicant’s claim for foreign priority to IN201921014894 filed 12 April 2019 under 35 U.S.C. 119 (a)-(d). Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55.
Accordingly, the effective filing date of the claimed invention is 12 April 2019.
Claim Objections
The objection to claims 1-2, 6, and 16 in the Office action mailed 06 April 2026 has been withdrawn in view of claim amendments received 09 July 2026.
The following objection is newly recited and necessitated by claim amendment.
Claims 1 and 16 are objected to because of the following informalities.
Claim 1 recites “information about a presence or absence of plurality of pathways” in the second limitation on pg. 3, which is a grammatical error and should recite “a plurality of pathways”.
Claim 1 recites of “wherein the GPM map is created with microbial names corresponding to microbial genomes in the DEGB, and information about a presence or absence of [a] plurality of pathways…, and the GPM map has a value…”, which is grammatically incorrect and should recite “wherein the GPM map is created with microbial names corresponding to microbial genomes in the DEGB[[,]] and information about a presence or absence of [a] plurality of pathways…”, to increase clarity that “is created with” corresponds to both the microbial names and the information.
Claim 1 recites “identifying a list of partial pollutant degraders…, wherein partial pollutant degraders… and wherein the identified list…, wherein complete pollutant degraders…”, which is grammatically incorrect and should recite “identifying a list…, wherein…, [[and]] wherein the identified list…, and wherein complete….”.
Claim 1 recites “designing a first microbial consortia using the created map of microbes comprising of microbes”, which should be amended to recite “designing a first microbial consortia, using the created map of microbes, comprising of microbes” to increase clarity that the consortia comprises the microbes.
Claim 16 recites “wherein the map of microbes is obtained from, and capable of degrading each pollutant…is created….”, which is nonsensical and should read “wherein the map of microbes capable of degrading each pollutant…is created using…”.
Claim 16 recites “…wherein this information is used…comprising each of the one or more pollutants identified in the sample, organisms capable…”, which is a grammatical error and should recite “comprising each of the one or more pollutants identified in the sample[[,]] and organisms capable…”
Appropriate correction is required.
Response to Arguments
Applicant’s arguments filed 01 July 2026 regarding the claim objections have been fully considered but they do not pertain to the newly recited objections set forth above.
Claim Rejections - 35 USC § 112(b)
The rejection of claims 4-5 under 35 U.S.C. 112(b) in the Office action mailed 06 April 2026 has been withdrawn in view of the cancellation of these claims received 21 July 2026
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
Claims 1-3, 6-9, 11, and 16 are rejected under 35 U.S.C. 112(b) as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor. This rejection contains newly cited portions necessitated by claim amendment and after further consideration of the claims.
Claim 1, and claims dependent therefrom, are indefinite for recitation of “wherein the partial degradation pathway in the given microbe…”. Claim 1 previously recites “information pertaining to complete degradation pathways and partial degradation pathways” and “a list of microbes…possessing a particular complete or partial pollutant degradation pathway”. Therefore, it is unclear if the wherein clause pertaining to “the partial degradation pathway” is further limiting a partial degradation pathway of the information stored in the knowledgebase or the particular partial degradation pathway of the list of microbes. Clarification is requested via claim amendment. This rejection is previously cited.
Claim 1, and claims dependent therefrom, are indefinite for recitation of “designing a first microbial consortia…comprising of microbes which together contribute…and wherein the microbes can survive…”. Clam 1 previously recites “a database of environmental microbes”, “microbes that contribute one or more sub-pathways” in the “identifying a list of partial pollutant degraders” step. As a result, it is not clear which microbes, “the microbes” is referring to. For purpose of examination, the limitation is interpreted to mean “wherein the microbes forming the first microbial consortia …”. This rejection is newly recited.
Claim 2 is indefinite for recitation of “the degradation pathway(s)” in lines 3, 4, 8 of the third limitation. Claim 2 previously recites “employing literature mining to identify degradation pathway(s)” in the first limitation and then recites “creating…using identified degradation pathway(s)” in lines 1-2 of the third limitation. It is not clear if “the degradation pathway(s)” is referring to the identified degradation pathways of the first limitation or the identified degradation pathway(s) in the third limitation, or if these are all intended to be the same degradation pathway(s). For purpose of examination, claim 2 is interpreted “creating…using the identified degradation pathway(s)”, such that the degradation pathway(s) are the same in each instance. This rejection is newly recited and necessitated by clam amendment.
Claim 2 is indefinite for recitation of “employing the literature mining…, wherein the DEBG comprises of the information pertaining to the microbes and the respective environmental niches in which the microbes thrive…” at the top of pg. 6. Claim 2 previously recites “employing literature mining to identify…corresponding genes/proteins in microbes, wherein the literature mining also results in identification of a set of microbes….”. Claim 1 previously recites “a list of microbes”, “information about respective environmental niches in which the microbes thrive”, “designing a first microbial consortia…comprising of microbes”, and “a second microbial consortia…comprising of microbes”. As a result, it is not clear what microbes “the microbes” at the top of pg. 6 are referring to, and similarly what environmental niches, the “environmental niches in which the microbes thrive” is referring to. This rejection is newly recited and necessitated by claim amendment.
Claim 6 is indefinite for recitation of “the microbial genomes”. Claim 2, from which claim 6 depends recites both “genomes of a plurality of microbes” and “microbial genomes in the DEBG”, and therefore it is not clear which genomes are being referenced. Claim 6 is interpreted to mean “identified in the microbial genomes in the DEBG”. This rejection is newly recited and necessitated by claim amendment.
Claim 7 is indefinite for recitation of “the presence of secretion capacity for each enzyme”. Claim 6 recites “each enzyme corresponding to each step of a sub-pathway identified in the microbial genomes”, claim 2 also recites “enzymes corresponding to each of the plurality of subpathways”, and claim 1 recites “enzymes for subpathways required for partial degradation…”. As a result, it is not clear what set of enzymes “each enzyme” in claim 7 is referring to. For purpose of examination, claim 7 is interpreted to mean “testing a presence of secretion capacity for each enzyme corresponding to each step of a sub-pathway identified in the microbial genomes”. This rejection is newly recited.
Claim 9 is indefinite for recitation of “a set of intermediate products derived… which, have a plurality of industrial applications”. When a subjective term is used in the claim, the examiner should determine whether the specification supplies some objective standard for measuring the scope of the term. Some objective standard must be provided in order to allow the public to determine the scope of the claim. A claim term that requires the exercise of subjective judgment without restriction may render the claim indefinite. See MPEP 2173.05(b). In the instant case, the metes and bounds of which intermediate products may or may not have “industrial applications” is subjective to a user of the invention. This rejection is newly recited and necessitated by claim amendment.
Claim 16 is indefinite for recitation of “the microbes from the GPM matrix having value 1…” in line 5. The limitation lacks antecedent basis because claim 1 does not previously recite a GPM matrix. As a result, it is also not clear which microbes “the microbes from the GPM matrix having value 1” are referring to. This rejection is newly recited and necessitated by claim amendment.
Claim 16 is indefinite for recitation of “…this information” in line 9. Claim 16 previously recites “information about an environmental niche” and claim 1 previously recites “information of the identified one or more pollutants; information pertaining to complete degradation…”, etc. As a result, it is not clear which information “the information” is referring to. The limitation is interpreted to mean “the information about an environmental niche where the microbes in the third matrix thrive…”. This rejection is newly recited.
Claim 16 is indefinite for recitation of “wherein the map of microbes is obtained from, and capable of degrading each pollutant…is created using the knowledgebase, wherein a first matrix is created…, a second matrix is created…., and a third matrix is created…wherein this information is used to create a Pollutant Organism Environment matrix (POEM)…”. Examples of claim language, although not exhaustive, that may raise a question as to the limiting effect of the language in a claim are: (B) "wherein" clauses. See MPEP 2111.04 I., e.g., Griffin v. Bertina, 285 F.3d 1029, 1034, 62 USPQ2d 1431 (Fed. Cir. 2002) (finding that a "wherein" clause limited a process claim where the clause gave "meaning and purpose to the manipulative steps"). In the instant case, it is not clear if the limitations “wherein a first matrix is created…a second matrix is created…a third matrix is created…wherein this information is used…” are expression an intended result of some other process step or if Applicant intends for creating the map of microbes to comprise creating a first matrix, etc. For purpose of examination, claim 16 is interpreted to mean that the step of creating the map of microbes using the knowledgebase in claim 1 comprises creating the first, second, and third matrix, and using the information to create the POEM. If Applicant agrees with this interpretation, the limitation can be amended similar to “The method according to claim 1, wherein the map of microbes created using the knowledgebase is created by: creating a first matrix, creating a second matrix using…, creating a third matrix of candidate organisms…, and using the information…to create a…(POEM)…”. This rejection is newly recited.
Response to Arguments
Applicant's arguments filed 23 Jan. 2026 regarding 25 U.S.C. 112(b) have been fully considered but they are not persuasive with respect to the outstanding rejections above.
Applicant remarks the claim is amended to recite “a particular complete or partial…wherein the particular complete degradation pathway…”, which overcomes the rejection (Applicant’s remarks at pg. 13, para. 4).
This argument is not persuasive because “the partial degradation pathway” is still indefinite as discussed above, because the term “particular” was not added for the partial pathway as it was for the complete pathway.
Applicant’s remaining arguments have been fully considered, but they do not pertain to the outstanding rejection set forth above.
Conclusion
No claims are allowed.
Claims 1-3, 6-9, 11, and 16 are patent eligible for the reasons discussed in the Office action mailed 05 Nov. 2025.
Claims 1-3, 6-9, 11, and 16 appear free of the prior art for the reasons discussed in the Office action mailed 05 Nov. 2025.
Inquiries
Any inquiry concerning this communication or earlier communications from the examiner should be directed to KAITLYN L MINCHELLA whose telephone number is (571)272-6485. The examiner can normally be reached 7:00 - 4:00 M-Th.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Olivia Wise can be reached at (571) 272-2249. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/KAITLYN L MINCHELLA/Primary Examiner, Art Unit 1685